Pain Management in Older Adults Before and During the First Year of COVID-19 Pandemic: Prevalence, Trends, and Correlates

Author:

Manhapra Ajay12,Fortinsky Richard H3,Berg Karina M3,Ross Joseph S45,Rhee Taeho Greg16

Affiliation:

1. Department of Psychiatry, Yale School of Medicine , New Haven, Connecticut , USA

2. Hampton VA Medical Center , Hampton, Virginia , USA

3. Center on Aging, University of Connecticut Health , Farmington, Connecticut , USA

4. Section of General Internal Medicine, Department of Medicine, Yale School of Medicine , New Haven, Connecticut , USA

5. Center for Outcomes Research and Evaluation, Yale-New Haven Health , New Haven, Connecticut , USA

6. Mood Disorders and Aging-related Research Program (MDARP), Department of Public Health Sciences, University of Connecticut School of Medicine , Farmington, Connecticut , USA

Abstract

Abstract Background There is limited knowledge on whether and how health care access restrictions imposed by the coronavirus disease of 2019 pandemic have affected utilization of both opioid and nonpharmacological treatments among US older adults living with chronic pain. Methods We compared prevalence of chronic pain and high impact chronic pain (ie, chronic pain limiting life or work activities on most days or every day in the past 6 months) between 2019 (pre-pandemic) and 2020 (first year of pandemic) and utilization of opioids and nonpharmacological pain treatments among adults aged ≥65 years enrolled in the National Health Interview Survey, a nationally representative sample of noninstitutionalized civilian U.S. adults. Results Of 12 027 survey participants aged ≥65 (representing 32.6 million noninstitutionalized older adults nationally), the prevalence of chronic pain was not significantly different from 2019 (30.8%; 95% confidence interval [CI], 29.7%–32.0%) to 2020 (32.1%; 95% CI, 31.0%–33.3%; p = .06). Among older adults with chronic pain, the prevalence of high impact chronic pain was also unchanged (38.3%; 95% CI, 36.1%–40.6% in 2019 versus 37.8%; 95% CI, 34.9%–40.8% in 2020; p = .79). Use of any nonpharmacological interventions for pain management decreased significantly from 61.2% (95 CI, 58.8%–63.5%) in 2019 to 42.1% (95% CI, 40.5%–43.8%) in 2020 (p < .001) among those with chronic pain, as did opioid use in the past 12 months from 20.2% (95% CI, 18.9%–21.6%) in 2019 to 17.9% (95% CI, 16.7%–19.1%) in 2020 (p = .006). Predictors of treatment utilization were similar in both chronic pain and high-impact chronic pain. Conclusion Use of pain treatments among older adults with chronic pain declined in the first year of coronavirus disease of 2019 pandemic. Future research is needed to assess long-term effects of coronavirus disease of 2019 pandemic on pain management in older adults.

Funder

National Institute on Aging

Publisher

Oxford University Press (OUP)

Subject

Geriatrics and Gerontology,Aging

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. What’s going on with Covid-19 right now?;Anaesthesia Critical Care & Pain Medicine;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3